1Lenardo MJ.Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system.Immunol Research,2003,27:387.
2Rieux LF,Deist F,Fischer A.Autoimmune lymphoproliferative syndromes:genetic defects of apoptosis pathways.Cell Death Differ,2003,10:124.
3Straus SE,Sneller M,Lenardo MJ,et al.An inherited disorder of lymphocyte apoptosis:the autoimmuno lymphoproliferative syndrome.Ann Int Med,1999,130:591.
4Lenardo MJ.Interleukin-2 programs mature alpha beta T cells for apoptosis.Nature,1991,353:858.
5Critchfield JM,Racke MK,Zuniga PJC,et al.T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.Science,1994,263:1139.
6Lenardo MJ,Chan FKM,Homung F,et al.Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment.Ann Rev Immunol,1999,17:221.
7Rieux LF,LeDeist F,Hivroz C,et al.Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.Science,1995,268:1347.
8Drappa J,Vaishnaw AK,Sullivan KE,et al.Fas gene mutations in the Canale-Smith syndrome,an inherited lymphoproliferative disordere associated with autoimmunity.N Engl J Med,1996,335:1643.
3Lenardo MJ. Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system [ J ]. Immunol Res, 2003,27 ( 2- 3 ) :387-398.
4Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoprolifera- tive syndromes : genetic defects of apoptosis pathways [ J ]. Cell Death and Differentiation, 2003,10 ( 1 ) : 124-133.
5Chun HJ,Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodefi- ciency[ J]. Nature ,2002,419 (6905) :395-399.
6Oliveira JB, Bidere N, Niemela JE, et al. NRAS mutation causes a hu- man autoimmune lymphoproliferative syndrome[ J ]. Proc Natl Acad Sci USA,2007,104(21 ) :8953-8958.
7Van der Werff ten Bosch J. Autoimmune lymphoproliferative syn- drome : etiology, diagnosis, and management [ J ]. Paediatr Drugs, 2003,5(3) :185-193.
8Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis [ J]. Blood,2001, 98(1) :194-200.
9Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome: report from the 2009 NIH International Workshop [ J ]. Blood ,2010, 116(14) :35-40.
10Campagnoli MF, Garbarini L, Quarello P, et al. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical fea- tures and long-term follow-up in 31 patients [ J ]. Haematologica, 2006,91 (4) :538-541.
